Trial Profile
High-activity Natural Killer Immunotherapy for Small Metastases of Nasopharyngeal Cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Sep 2019
Price :
$35
*
At a glance
- Drugs Natural killer cell therapy Shenzhen Hank Bioengineering Institute (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 10 Sep 2019 Status changed from recruiting to completed.
- 10 Jan 2017 New trial record